Targeted therapies: Combined lapatinib and paclitaxel in HER2-positive breast cancer

Carlos A. Castañeda; Henry L. Gomez

doi:10.1038/nrclinonc.2009.68

Targeted therapies: Combined lapatinib and paclitaxel in HER2-positive breast cancer

Carlos A. Castañeda
, Henry L. Gomez

Instituto Nacional de Enfermedades Neoplásicas Eduardo Cáceres Graziani

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Original language	English
Pages (from-to)	308-309
Number of pages	2
Journal	Nature Reviews Clinical Oncology
Volume	6
Issue number	6
DOIs	https://doi.org/10.1038/nrclinonc.2009.68
State	Published - 2009
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/nrclinonc.2009.68

Cite this

@article{9ddd647384834692a1159bf4a013d2b9,

title = "Targeted therapies: Combined lapatinib and paclitaxel in HER2-positive breast cancer",

author = "Casta{\~n}eda, \{Carlos A.\} and Gomez, \{Henry L.\}",

year = "2009",

doi = "10.1038/nrclinonc.2009.68",

language = "Ingl{\'e}s",

volume = "6",

pages = "308--309",

journal = "Nature Reviews Clinical Oncology",

issn = "1759-4774",

number = "6",

}

TY - JOUR

T1 - Targeted therapies

T2 - Combined lapatinib and paclitaxel in HER2-positive breast cancer

AU - Castañeda, Carlos A.

AU - Gomez, Henry L.

PY - 2009

Y1 - 2009

UR - https://www.scopus.com/pages/publications/68549121149

U2 - 10.1038/nrclinonc.2009.68

DO - 10.1038/nrclinonc.2009.68

M3 - Artículo

C2 - 19483734

AN - SCOPUS:68549121149

SN - 1759-4774

VL - 6

SP - 308

EP - 309

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

IS - 6

ER -

Targeted therapies: Combined lapatinib and paclitaxel in HER2-positive breast cancer

UN SDGs

Access to Document

Other files and links

Cite this